Decreased Diversity of the Fecal Microbiome in Recurrent Clostridium difficile–Associated Diarrhea
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Antibiotic-associated diarrhea due to Clostridium difficile (CDAD) is thought to reflect colonization of a disrupted microbial community by the pathogen. We profiled the fecal microbiota of patients with CDAD (both initial and recurrent episodes) by culture-independent phylogenetic analysis of 16S rRNA-encoding gene sequences. Compared with those from control subjects and patients with an initial episode, the fecal communities in patients with recurrent CDAD were highly variable in bacterial composition and were characterized by markedly decreased diversity. Preservation and restoration of the microbial diversity could represent novel strategies for prevention and treatment of recurrent CDAD, which is often recalcitrant to existing therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, a small, open label pilot study comparing upper and lower GI routes of administration did not show any differences44”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [44]
In the citing paper
“The human gut microbiota can restrict the growth of pathogens to prevent them from colonizing the intestine (‘colonization resistance’).”
From Role of the gut microbiota in nutrient competition and protection against intestinal pathogen colonization (2023) · cites this paper as [28]
In the citing paper
“Gut microbiota with high diversity have higher colonization resistance than gut microbiota with low diversity as a result of antibiotic treatment [28].”
From Role of the gut microbiota in nutrient competition and protection against intestinal pathogen colonization (2023) · cites this paper as [28]
Citations
Cites
Measuring biological diversity
(2004) · Choice Reviews Online · doi:10.5860/choice.42-1547 · Cited by 6,621
Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358 · cited 3×
“exist in a complex symbiosis with their host [5].”
BackgroundInfluentialSchloss, P. D., & Handelsman, J. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.3.1501-1506.2005 · Cited by 2,501 · cited 1×
“The distance matrix was fed into DOTUR [8] to group the sequences into operational taxonomic units (OTUs), calculate ecological diversity measures (including the Shannon index [9]), and generate rarefaction curves by use of an OTU definition of 97% sequence similarity.”
MethodAntibiotic-Associated Diarrhea
Bartlett, J. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011603 · Cited by 1,197 · cited 1×
“Diarrhea is a common side effect of the administration of antibiotics, with Clostridium difficile being responsible for most of the severe cases of antibiotic-associated diarrhea (AAD), including the development of pseudomembranous colitis [1].”
BackgroundMcFarland, L. V. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00465.x · Cited by 872 · cited 1×
“difficile antibiotics or the administration of probiotic organisms— have been tried for treatment of RCD [12, 13] [14].”
BackgroundKyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03592-3 · Cited by 804 · cited 1×
“difficile toxin [11].”
Breaking The Cycle: Treatment Strategies for 163 Cases of Recurrent Clostridium Difficile Disease
McFarland, L. V., Elmer, G. W., & Surawicz, C. M. (2002) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05839.x · Cited by 724 · cited 1×
“difficile antibiotics or the administration of probiotic organisms— have been tried for treatment of RCD [12, 13] [14].”
BackgroundAas, J., Gessert, C. E., & Bakken, J. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367657 · Cited by 518 · cited 1×
“individuals to patients with RCD [4, 15]—is to alter the patient’s microbiome and to restore colonization resistance.”
BackgroundBACTERIOTHERAPY FOR CHRONIC RELAPSING CLOSTRIDIUM DIFFICILE DIARRHOEA IN SIX PATIENTS
Tvede, M., & Rask-Madsen, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92749-9 · Cited by 491
Vollaard, E. J., & Clasener, H. A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.409 · Cited by 478 · cited 1×
“microbiota is that of “colonization resistance” [10].”
Cited by
Items 501–600 of 999
Pedrogo, D. A. M., Sears, C. L., & Melia, J. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae061 · Cited by 32
Investigational new treatments for Clostridium difficile infection
Ivarsson, M. E., Leroux, J., & Castagner, B. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.12.003 · Cited by 33
Bulow, C., Langdon, A. E., Hink, T., Wallace, M. A., Reske, K. A., Patel, S., Sun, X., Seiler, S. M., Jones, S., Kwon, J. H., et al. (2018) · mSphere · doi:10.1128/mspheredirect.00588-18 · Cited by 28
Association of gut dysbiosis with intestinal metabolites in response to antibiotic treatment
Khan, T. J., Hasan, M. N., Azhar, E. I., & Yasir, M. (2019) · Human Microbiome Journal · doi:10.1016/j.humic.2018.11.004 · Cited by 35
Scheeler, A. (2019) · The Journal of Law Medicine & Ethics · doi:10.1177/1073110519897729 · Cited by 30
Gastrointestinal Disorders and Risk of First-Ever Ischemic Stroke
Roth, W., Cai, A., Zhang, C., Chen, M. L., Merkler, A. E., & Kamel, H. (2020) · Stroke · doi:10.1161/strokeaha.120.030643 · Cited by 32
Conover, K. R., Absah, I., Ballal, S. A., Brumbaugh, D. E., Cho, S., Cardenas, M. C., Knackstedt, E. D., Goyal, A., Jensen, M. K., Kaplan, J. L., et al. (2023) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003714 · Cited by 32
“However, it is important to consider that patients with rCDI have expansion of invasive bacterial species including members of the genus Enterobacteriaceae (28,29).”
BackgroundVázquez‐Cuesta, S., Villar-Gómara, L., Lozano-García, N., Fernández, A. I., Olmedo, M., Alcalá, L., Marín, M., Muñóz, P., Bouza, E., & Reigadas, E. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1130701 · Cited by 30
“Consistent with the literature, the lowest diversity and richness values were recorded for patients with R-CDI (Chang et al., 2008; Allegretti et al., 2016; Gazzola et al., 2020).”
ResultHan, S. S., Shannahan, S. E., & Pellish, R. S. (2016) · Journal of Intensive Care Medicine · doi:10.1177/0885066615594344 · Cited by 34
“Colonization resistance provides a protective function to the host’s own indigenous gut flora, which when present in sufficient quantity and diversity limits the colonization of pathogenic bacteria.(30-34) In addition to exposure to certain antibiotics, other risk factors that increase the risk of initial CDI include…”
BackgroundFidaxomicin Failures in Recurrent Clostridium difficile Infection: A Problem of Timing
Orenstein, R. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis495 · Cited by 26
Saccharomyces boulardii for the Prevention of Hospital Onset Clostridium difficile Infection
Flatley, E. A., Wilde, A. M., & Nailor, M. D. (2015) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld.2014.1121.fly · Cited by 28
“Fecal bacterial species are less diverse in patients with recurrent CDI as compared to patients without CDI or with their first occurrence of the disease [6].”
Gut microbiota and Clostridium difficile infections
Lagier, J. (2016) · Human Microbiome Journal · doi:10.1016/j.humic.2016.10.003 · Cited by 28
Fecal transplantation for the treatment of recurrentClostridium difficileinfection
Karadsheh, Z., & Sule, S. S. (2013) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.114163 · Cited by 29
“,[44] analyzed the fecal microbiota of seven patients with CDI using 16S rDNA sequencing, they found marked reduction of Bacteroidetes phyla and an increased numbers of Proteobacteria and Verrucomicrobia phyla, both are usually minor in noninfected individuals.”
BackgroundDiagnosis and Management of Clostridium difficile Infection
Korman, T. M. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0034-1398741 · Cited by 34
Salger, S. A., Reza, J., Deck, C. A., Wahab, M. A., Baltzegar, D. A., Murr, A. T., & Borski, R. J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236100 · Cited by 31
Boekhoud, I. M., Michel, A., Corver, J., Jahn, D., & Smits, W. K. (2020) · mSphere · doi:10.1128/msphere.00728-20 · Cited by 25
“The physiological response of C. difficile to these insults and the inflammatory responses triggered by CDI can result in the production of Reactive Oxygen Species (ROS), Reactive Nitrogen Species (RNS) and nitric oxide (NO) (2, 6).”
BackgroundInfluentialDietary fat promotes antibiotic-induced Clostridioides difficile mortality in mice
Hazleton, K. Z., Martin, C. G., Orlicky, D. J., Arnolds, K. L., Nusbacher, N. M., Moreno-Huizar, N., Armstrong, M., Reisdorph, N. A., & Lozupone, C. (2022) · npj Biofilms and Microbiomes · doi:10.1038/s41522-022-00276-1 · Cited by 30
Bolsega, S., Bleich, A., & Basic, M. (2021) · Nutrients · doi:10.3390/nu13114173 · Cited by 29
“, the overgrowth of Clostridioides difficile (former Clostridium difficile) in the intestine, which can lead to infectious colitis due to the impaired intestinal defenses [70,71].”
BackgroundYang, J. W., Hocking, D. M., Cheng, C., Dogovski, C., Perugini, M. A., Holien, J. K., Parker, M. W., Hartland, E. L., Tauschek, M., & Robins-Browne, R. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.503912 · Cited by 25
“Unlike conventional antibiotics, which disrupt the intestinal microbiota and encourage overgrowth of pathogens such as Clostridium difficile (54), small molecule inhibitors that specifically target virulence regulatory pathways should not cause a growth disadvantage of the bacterial pathogen or commensal bacteria, whi…”
BackgroundShaban, L., Ying, C., Fasciano, A. C., Lin, Y., Kaplan, D. L., Kumamoto, C. A., & Mecsas, J. C. (2018) · Anaerobe · doi:10.1016/j.anaerobe.2018.02.006 · Cited by 25
Graul, T., Cain, A. M., & Karpa, K. D. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.02.026 · Cited by 32
“Additionally, it appears that combinations of different bacterial genera may be necessary to maximize therapeutic benefits [45].”
BackgroundRashidi, A., & Weisdorf, D. J. (2020) · Translational research · doi:10.1016/j.trsl.2020.03.011 · Cited by 26
Wurster, J. I., Peterson, R. L., Brown, C. E., Penumutchu, S., Guzior, D. V., Neugebauer, K. A., Sano, W. H., Sebastian, M. M., Quinn, R. A., & Belenky, P. A. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110113 · Cited by 24
“This alters the intestinal metabolome, placing the host at higher risk for opportunistic infection (Bäumler and Sperandio, 2016; Buffie et al., 2012; Chang et al., 2008; Croswell et al., 2009; Kaiko and Stappenbeck, 2014; Rivera-Chávez et al., 2016; Theriot et al., 2016; Theriot and Young, 2015).”
BackgroundFecal microbiota transplantation in childhood: past, present, and future
Gu, X., Chen, Z.-H., & Zhang, S. (2022) · World Journal of Pediatrics · doi:10.1007/s12519-022-00655-w · Cited by 26
Gut microbiome–based therapeutics in inflammatory bowel disease
Hu, K. A., & Gubatan, J. M. B. (2023) · Clinical and Translational Discovery · doi:10.1002/ctd2.182 · Cited by 27
Balasubramanian, I., Bandyopadhyay, S., Flores, J., Bianchi‐Smak, J., Lin, X., Liu, H., Sun, S., Golovchenko, N. B., Liu, Y., Wang, D., et al. (2023) · The EMBO Journal · doi:10.15252/embj.2023113975 · Cited by 25
Secco, D., Balassiano, I. T., Boente, R. F., Miranda, K. R., Brazier, J., Hall, V., dos Santos-Filho, J., Lobo, L. A., Nouér, S. A., & Domingues, R. M. C. P. (2014) · Anaerobe · doi:10.1016/j.anaerobe.2014.05.013 · Cited by 24
“difficile in the colon results from the removal of members of the normal intestinal flora in consequence of antibiotic therapy [4,5].”
The Effect of Probiotic Treatment on Patients Infected with the H7N9 Influenza Virus
Hu, X., Zhang, H., Lu, H., Qian, G., Lv, L., Zhang, C., Guo, J., Jiang, H., Zheng, B., Yang, F., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151976 · Cited by 25
Cataldo, M. A., Granata, G., & Petrosillo, N. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1387535 · Cited by 28
Probiotics in luminal gastroenterology: the current state of play
Andrews, J. M., & Tan, M. (2012) · Internal Medicine Journal · doi:10.1111/imj.12015 · Cited by 33
Perturbations in gut microbiota in autism spectrum disorder: a systematic review
Tao, X., Li, Z., Wang, D., Pu, J., Liu, Y., Gui, S., Zhong, X., Yang, D., Zhou, H., Tao, W., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1448478 · Cited by 23
“There is an assumption that a higher diversity of gut microbiota symbolizes a healthy state (Shade, 2017), while a lower α -diversity is considered a marker of disease status (Chang et al., 2008).”
Berry, P., & Khanna, S. (2023) · BioDrugs · doi:10.1007/s40259-023-00617-2 · Cited by 23
Walk, S. T., & Young, V. B. (2008) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2008/125081 · Cited by 29
Self-citationJiang, Z.-D., Hoang, L. N., Lasco, T. M., Garey, K. W., & DuPont, H. L. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis1025 · Cited by 23
Park, L., Mone, A., Price, J. C., Tzimas, D., Hirsh, J., Poles, M. A., Malter, L., & Chen, L. A. (2016) · Annals of Gastroenterology · doi:10.20524/aog.2016.0098 · Cited by 28
“While the specific mechanism by which FMT treats CDAD is unknown, several studies have suggested that re-establishment of a diverse gut microbiome is key [17-19].”
BackgroundChehri, M., Christensen, A. H., Halkjær, S. I., Günther, S., Petersen, A. M., & Helms, M. (2018) · Medicine · doi:10.1097/md.0000000000011706 · Cited by 25
“Chang et al[14] showed that patients with rCDI had a significant decreased diversity of the gut microbiome compared with healthy controls and patients with an initial episode of CDI, and this could indicate that repopulating the altered gut microbiota of patients with rCDI with FMT material from multiple universal don…”
BackgroundLactobacillus rhamnosusGG reverses mortality of neonatal mice againstSalmonellachallenge
Naik, A. K., Pandey, U., Mukherjee, R., Mukhopadhyay, S., Chakraborty, S., Ghosh, A., & Aich, P. (2019) · Toxicology Research · doi:10.1039/c9tx00006b · Cited by 23
The, S., Bakx, R., Budding, A. E., de Meij, T. G. J., van der Lee, J. H., Bunders, M. J., Poort, L., Heij, H. A., van Heurn, E. L. W., & Gorter, R. R. (2019) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002434 · Cited by 28
“150 Faecalibacterium prausnitzii 13 (36) 4 (25) 10 (50) 0.”
Role of the Intestinal Microbiota in Host Responses to Stressor Exposure
Mackos, A. R., Varaljay, V. A., Maltz, R. M., Gur, T., & Bailey, M. T. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.08.002 · Cited by 30
Temporal Differential Proteomes of Clostridium difficile in the Pig Ileal-Ligated Loop Model
Janvilisri, T., Scaria, J., Teng, C., McDonough, S. P., Gleed, R. D., Fubini, S. L., Zhang, S., Akey, B., & Chang, Y.-F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045608 · Cited by 22
Microbiome Anomalies in Allogeneic Hematopoietic Cell Transplantation
Schwabkey, Z. I., & Jenq, R. R. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-052918-122440 · Cited by 23
Faecal microbiota transplantation—the Austrian approach
Kump, P. K., Krause, R., Allerberger, F. J., & Högenauer, C. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12801 · Cited by 23
“Specific alterations in the intestinal microbiota, termed dysbiosis, seem to be involved in the pathogenesis of a variety of intestinal and extra-intestinal diseases, such as intestinal infections, inflammatory bowel disease (IBD), irritable bowel syndrome, metabolic syndrome, and autoimmune diseases [2–9].”
BackgroundRole of Gut-Brain Axis in the Aetiology of Neurodevelopmental Disorders with Reference to Autism
Rizk, M. Z. (2012) · Journal of Clinical Toxicology · doi:10.4172/2161-0495.s6-005 · Cited by 24
Brandt, L. J. (2015) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000346 · Cited by 24
Bansal, S., Nguyen, J., Leligdowicz, A., Zhang, Y., Kain, K. C., Ricciuto, D. R., & Coburn, B. A. (2018) · mSphere · doi:10.1128/msphere.00219-18 · Cited by 28
Richards, E. J., Bouché, L., Panico, M., Arbeloa, A., VINOGRADOV, E. V., Morris, H. R., Wren, B. W., Logan, S. M., Dell, A., & Fairweather, N. F. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004530 · Cited by 24
Evaluation of Skin Colonisation And Placement of vascular access device Exit sites (ESCAPE Study)
Moureau, N., Marsh, N. M., Zhang, L., Bauer, M. J., Larsen, E. N., Mihala, G., Corley, A., Lye, I., Cooke, M. L., & Rickard, C. M. (2018) · Journal of Infection Prevention · doi:10.1177/1757177418805836 · Cited by 23
Vigsnæs, L. K., Ghyselinck, J., den Abbeele, P. V., McConnell, B., Moens, F., Marzorati, M., & Bajic, D. (2021) · Pathogens · doi:10.3390/pathogens10080927 · Cited by 24
Gastrointestinal Microbial Ecology with Perspectives on Health and Disease
Gillilland, M. G., Young, V. B., & Huffnagle, G. B. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00040-3 · Cited by 29
Self-citationImpact of Surotomycin on the Gut Microbiota of Healthy Volunteers in a Phase 1 Clinical Trial
Citron, D. M., Tyrrell, K. L., Dale, S. E., Chesnel, L., & Goldstein, E. J. C. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02531-15 · Cited by 22
“The human intestinal tract is colonized with a variety of commensal beneficial microorganisms that reside in a delicate balance, providing protection against potential pathogens (1).”
BackgroundThe Present Status of Fecal Microbiota Transplantation and Its Value in the Elderly
Cheng, Y., & Fischer, M. (2017) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-017-0143-1 · Cited by 24
“difficile and subsequent toxin production [11, 12].”
Leśniak–Ziółkowska, K., Kazek‐Kęsik, A., Rokosz, K., Raaen, S., Stolarczyk, A., Krok−Borkowicz, M., Pamuła, E., & Simka, W. (2021) · Applied Surface Science · doi:10.1016/j.apsusc.2021.150284 · Cited by 22
Influence of gut microbiome on the human physiology
Srivastava, A., Prabhakar, M. R., Mohanty, A., & Meena, S. S. (2021) · Systems Microbiology and Biomanufacturing · doi:10.1007/s43393-021-00052-w · Cited by 28
Sex-Dependent Effects of Inhaled Nicotine on the Gut Microbiome
Whitehead, A., Meyers, M. C., Taylor, C. M., Luo, M., Dowd, S. E., Yue, X., & Byerley, L. O. (2022) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntac064 · Cited by 22
New Perspectives in Clostridium difficile Disease Pathogenesis
Monaghan, T. M. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2014.11.007 · Cited by 30
Effects of Tigecycline and Vancomycin Administration on Established Clostridium difficile Infection
Theriot, C. M., Schumacher, C. A., Bassis, C. M., Seekatz, A. M., & Young, V. B. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04296-14 · Cited by 24
“Alterations in the gut microbiota from antibiotics used to treat CDI patients have been associated with recurrent CDI (32).”
BackgroundSelf-citationVandell, A. G., Inoue, S., Dennie, J. G., Nagasawa, Y., Gajee, R., Joe, P., Zhang, G., Zamora, C. A., Masuda, N., & Senaldi, G. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02537-17 · Cited by 21
“difficile colonization (20), with reduced microbial diversity being observed in patients with CDI and even more reduced microbial diversity being observed in patients with recurrent CDI (21).”
BackgroundFecal microbiota transplantation in children: current concepts
Gurram, B., & Sue, P. K. (2019) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000787 · Cited by 23
“In addition, microbial signatures demonstrating decreased gut microbiota and phyla diversity have been shown to predispose individuals to CDI [6].”
BackgroundVindigni, S. M., Broussard, E. K., & Surawicz, C. M. (2013) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2013.832501 · Cited by 24
Tesfaw, G., Siraj, D. S., Abdissa, A., Jakobsen, R. R., Johansen, Ø. H., Zangenberg, M., Hanevik, K., Mekonnen, Z., Langeland, N., Bjørang, O., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51464-w · Cited by 24
“This decrease in diversity has also been linked to Clostridiodes dif fi cile -associated diarrhea in adults 51,52 .”
Edelstein, C. A., Kassam, Z., Daw, J. R., Smith, M. B., & Kelly, C. R. (2015) · Clinical Research and Regulatory Affairs · doi:10.3109/10601333.2015.1046602 · Cited by 24
Alverdy, J. C., Gilbert, J. A., DeFazio, J. R., Sadowsky, M. J., Chang, E. B., Morowitz, M. J., & Teitelbaum, D. H. (2013) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607113517904 · Cited by 24
Woloszynek, S., Pastor, S. J., Mell, J. C., Nandi, N., Sokhansanj, B. A., & ROSEN, G. L. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.01.003 · Cited by 26
Silva, B. R. D. S., Derami, M. S., Paixão, D. A. A., Persinoti, G. F., da Silveira, W. D., & Maluta, R. P. (2020) · Aquaculture Research · doi:10.1111/are.14676 · Cited by 24
Pino, R. E. H. D., Barbero, A. M., Español, L. Á., Morro, L. S., & Pasquinelli, V. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.4vmr0720-201r · Cited by 25
Mohandas, S., Soma, V. L., Tran, T. D. B., Sodergren, E. J., Ambooken, T., Goldman, D. L., Weinstock, G. M., & Herold, B. C. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.583446 · Cited by 29
Henson, M. A. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008782 · Cited by 19
“difficile pathogenic colonization through a variety of metabolic mechanisms, including competition for dietary nutrients such as carbohydrates and amino acids [10] and conversion of host-derived primary bile acids that promote C.”
BackgroundOh, H., Min, U.-G., Jang, H.-J., Kim, N., Lim, J., Chalita, M., & Chun, J. (2022) · The Journal of Microbiology · doi:10.1007/s12275-022-1526-0 · Cited by 23
“Gut microbial diversity is also higher in healthy individuals than in those under diseased conditions (Chang et al., 2008; Pozuelo et al., 2015).”
BackgroundA Potent and Narrow-Spectrum Antibacterial against Clostridioides difficile Infection
Qian, Y., Birhanu, B. T., Yang, J., Ding, D., Janardhanan, J., Mobashery, S., & Chang, M. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01249 · Cited by 20
Song, D., Lee, J., Yoo, Y., Oh, H. J., Chang, S., An, J., Park, S., Jeon, K., Cho, Y., Yoon, Y., et al. (2023) · Journal of Animal Science and Technology · doi:10.5187/jast.2023.e119 · Cited by 28
Singhi, S. C., & Jayashre, M. (2009) · PubMed · Cited by 23
Fecal microbiota transplantation for recurrent Clostridium difficile infection in children
Chen, B., Avinashi, V., & Dobson, S. (2017) · Journal of Infection · doi:10.1016/s0163-4453(17)30202-5 · Cited by 19
van Beurden, Y. H., Nezami, S., Mulder, C. J. J., & Vandenbroucke‐Grauls, C. M. J. E. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.07.025 · Cited by 21
“It is generally assumed that the inability of the gut microbiota to re-establish colonization resistance after initial CDI adds to recurrence risk.(3,4) Alternatively, recurrent CDI may reflect failure of the host to mount a protective immune response against C.”
BackgroundGrześkowiak, Ł., Pieper, R., Huynh, H. A., Cutting, S. M., Vahjen, W., & Zentek, J. (2018) · Gut Microbes · doi:10.1080/19490976.2018.1518554 · Cited by 26
Voth, E. R., & Khanna, S. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1752192 · Cited by 23
“transit, medications, diet, hygiene, physical activity, stress and emotional health, tobacco use, and alcohol use all contribute to the composition and diversity of the microbiome [6,7,10,11].”
BackgroundZhang, Y., Wang, Z., Dong, Y., Cao, J., & Chen, Y. (2022) · Antioxidants · doi:10.3390/antiox11020274 · Cited by 20
Practical Use of RBX2660 for the Prevention of Recurrent Clostridioides difficile Infection
Feuerstadt, P., Allegretti, J. R., & Khanna, S. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002195 · Cited by 19
“depleted in such away that natural regrowthwould be a challenge, and supplementation with an LBP might be most beneficial (18).”
BackgroundSaenz, C., Fang, Q., Gnanasekaran, T., Trammell, S. A. J., Buijink, J. A., Pisano, P., Wierer, M., Moens, F., Lengger, B., Brejnrod, A., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03933-22 · Cited by 19
Thielman, N. M., & Wilson, K. H. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00096-5 · Cited by 20
Santiago, M., 1 Finch Therapeutics, 2. I. B. R., Eysenbach, L. M., Allegretti, J. R., Aroniadis, O. C., Brandt, L. J., Fischer, M., Grinspan, A. M., Kelly, C. R., Morrow, C. D., et al. (2019) · AIMS Microbiology · doi:10.3934/microbiol.2019.1.1 · Cited by 20
Jukes, C., Ijaz, U. Z., Buckley, A. M., Spencer, J., Irvine, J. J., Candlish, D., Li, J. V., Marchesi, J. R., & Douce, G. R. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1678996 · Cited by 19
“Such episodes reflect persistent disruption of the microbiota, creating an environment in which the pathogen can flourish.(6,7) Consequently, restoration of microbiota diversity has become the focus for new treatments including fecal microbiota transplantation (FMT),(8,9) defined bacterial therapies and more recently…”
BackgroundGut microbiota features associated with Clostridioides difficile colonization in puppies
Berry, A. S. F., Barnhart, D., Kelly, B. J., Kelly, D. J., Beiting, D. P., Baldassano, R. N., & Redding, L. E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215497 · Cited by 24
LaMonte, M. J., Genco, R. J., Zheng, W., McSkimming, D. I., Andrews, C., Hovey, K. M., Li, L., Sun, Y., Buck, M. J., Millen, A. E., et al. (2018) · Dentistry Journal · doi:10.3390/dj6040058 · Cited by 21
Bhute, S. S., Mefferd, C. C., Phan, J. R., Ahmed, M., Fox-King, A. E., Alarcia, S., Villarama, J. V., Abel‐Santos, E., & Hedlund, B. P. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01804-21 · Cited by 19
Non-Toxin-Based Clostridioides difficile Vaccination Approaches
Razim, A., Górska, S., & Gamian, A. (2023) · Pathogens · doi:10.3390/pathogens12020235 · Cited by 22
“, when the quantitative and qualitative composition of the intestinal bacterial microflora is disturbed [2].”
Clostridioides difficile infections; new treatments and future perspectives
Normington, C., Chilton, C. H., & Buckley, A. M. (2023) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000989 · Cited by 27
Li, Z., Li, L., Sokolova, I. M., Shang, Y., Huang, W., Waiho, K., Fang, J. K., Wang, Y., & Hu, M. (2024) · Marine Pollution Bulletin · doi:10.1016/j.marpolbul.2023.115979 · Cited by 19
Kualitas Sumber Air Minum dan Pemanfaatan Jamban Keluarga dengan Kejadian Diare
Wandansari, A. P. (2013) · doi:10.15294/kemas.v9i1.2826 · Cited by 21
Fecal microbiota transplantation for Clostridium difficile infection: back to the future
Borgia, G., Maraolo, A. E., Foggia, M., Buonomo, A. R., & Gentile, I. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1045872 · Cited by 22
“Indeed, bacterial diversity is notably diminished in fecal samples of patients affected by RCDI, that is, proportions of the Enterobacteriaceae family of g-Proteobacteria are increased and proportions of the Bacteroidetes and Firmicutes phyla are decreased [27].”
BackgroundMicrobiota restoration for recurrent Clostridioides difficile: Getting one step closer every day!
Khanna, S. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13290 · Cited by 23
The integration of sequencing and bioinformatics in metagenomics
Abbasian, F., Lockington, R. A., Megharaj, M., & Naidu, R. (2015) · Reviews in Environmental Science and Bio/Technology · doi:10.1007/s11157-015-9365-7 · Cited by 23
“In the case of prokaryotes, rDNA sequence with more than 97 % similarity are clustered as a species or an Operational Taxonomic Unit (OUT) (Chang et al. 2008; Turnbaugh et al. 2009).”
BackgroundEmerging drugs for the treatment of clostridium difficile
Cammarota, G., Gallo, A., Ianiro, G., & Montalto, M. (2019) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2019.1591371 · Cited by 21
“Molecular characterization of gut microbiota of patients with CDI demonstrates marked alterations of composition of gut microbiota, mainly when recurrent episodes of CDI occur [48].”
BackgroundClostridium difficile: an emerging pathogen in children.
Khalaf, N. I., Crews, J. D., DuPont, H. L., & Koo, H. L. (2012) · PubMed · Cited by 21
Host and microbiome features of secondary infections in lethal covid-19
Zacharias, M., Kashofer, K., Wurm, P., Regitnig, P., Schütte, M., Neger, M., Ehmann, S., Marsh, L. M., Kwapiszewska, G., Loibner, M., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104926 · Cited by 26
“difficile colitis; (Chang et al., 2008)), similar mechanisms might happen in the respiratory tract.”
Microbiota Profile of the Nasal Cavity According to Lifestyles in Healthy Adults in Santiago, Chile
Toro‐Ascuy, D., Cárdenas, J. P., Zorondo‐Rodríguez, F., González, D., Silva-Moreno, E., Puebla, C., Nunez-Parra, A., Reyes-Cerpa, S., & Fuenzalida, L. (2023) · Microorganisms · doi:10.3390/microorganisms11071635 · Cited by 20
“A loss of microbiota diversity has been associated with several diseases [64,65], while increased diversity is associated with a better state of health [66].”
Clostridium difficile Infection in the Postcolectomy Patient
Seril, D. N., & Shen, B. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000164 · Cited by 21
“Antibiotic treatment and subsequent CDI are associated with a reduction in the diversity of the intestinal microflora, whereas successful treatment of CDI results in a resurgence of bacterial diversity.(33) Our recent study showed that a preoperative use of antibiotics in patients with colectomy and IPAA was associate…”
BackgroundKaźmierczak-Siedlecka, K., Ruszkowski, J., Skonieczna‐Żydecka, K., Jędrzejczak, J., Folwarski, M., & Makarewicz, W. (2021) · Central European Journal of Immunology · doi:10.5114/ceji.2020.103353 · Cited by 22
Effect of DS-2969b, a novel GyrB inhibitor, on rat and monkey intestinal microbiota
Kumar, M., Mathur, T., Joshi, V., Upadhyay, D. J., Inoue, S., & Masuda, N. (2018) · Anaerobe · doi:10.1016/j.anaerobe.2018.04.017 · Cited by 17
Clostridioides difficile infection: traversing host–pathogen interactions in the gut
Cheng, J. K. J., & Unnikrishnan, M. (2023) · Microbiology · doi:10.1099/mic.0.001306 · Cited by 22
Gazzola, A., Panelli, S., Corbella, M., Merla, C., Comandatore, F., SILVESTRI, A. D., Piralla, A., Zuccaro, V., Bandi, C., Marone, P., et al. (2020) · Biomedicines · doi:10.3390/biomedicines8090335 · Cited by 18
“difficile infection is accompanied by a decrease in biodiversity indexes compared to non-infected controls, with a maximum (and statistical significance) in recurrent patients, in accordance with previous results [10,11,16,18].”
BackgroundResult
Metadata
- Authors
- Chang, J. Y., Antonopoulos, D. A., Kalra, A., Tonelli, A., Khalife, W. T., Schmidt, T. M., & Young, V. B.
- Affiliations
- Michigan State University (US)
- Corresponding author
- Young, Vincent B.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-02
- Volume
- 197
- Issue
- 3
- Pages
- 435-438
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2139607253
- Cited by
- 1,010
- References
- 15
- Citations by year
- 2026: 15 · 2025: 28 · 2024: 36 · 2023: 54 · 2022: 42 · 2021: 57 · 2020: 69 · 2019: 59 · 2018: 107 · 2017: 78 · 2016: 77 · 2015: 88 · 2014: 87 · 2013: 78 · 2012: 53
- FWCI
- 17.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Keywords
- Clostridium difficile, fecal microbiota, microbial diversity, antibiotic-associated diarrhea, 16S rRNA gene sequencing, bacterial community composition, dysbiosis, microbiota restoration
- MeSH terms
- Anti-Bacterial Agents, Diarrhea, Drug Administration Schedule, Enterocolitis, Pseudomembranous, Feces, Female, Humans, Male, Phylogeny, Recurrence, Reference Values, Genetic Variation, Clostridioides difficile
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.